Sanofi’s Global Head for Prostate Drug, Zhen Su, Leaves Company

Sanofi’s global head for prostate cancer drug Jevtana is leaving France’s biggest drugmaker.

To continue reading this article you must be a Bloomberg Professional Service Subscriber.